Current Duke Appointments & Affiliations
Biostatistician III
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Real-world early quality of life (QOL) changes on IO-based regimens in the prospective observational ODYSSEY metastatic renal cell carcinoma (mRCC) study.
Conference Journal of Clinical Oncology · March 1, 2026 Lack of standardized reporting and collection of patient-reported outcomes (PROs) limits cross-trial comparisons of first-line IO-based regimens for mRCC. Prospectively collected real world data may fill this important knowledge gap. Pts with stable/improv ... Full text CiteMarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics.
Journal article Ann Neurol · February 2026 OBJECTIVE: To establish a framework for validating candidate biomarkers of cerebral small vessel diseases (SVD) associated with cognitive impairment and characterize individuals enrolled by the MarkVCID2 consortium under this framework. METHODS: Participan ... Full text Link to item CiteUse of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting: Insights From the CAMEO Registry.
Journal article JACC Adv · December 2025 BACKGROUND: Little is known about the use of cangrelor in patients with acute myocardial infarction (AMI) undergoing coronary artery bypass grafting (CABG). OBJECTIVES: The purpose of this study was to examine characteristics and patterns of cangrelor util ... Full text Link to item CiteRecent Grants
VCID Biomarkers Coordinating Center
ResearchStatistician · Awarded by Massachusetts General Hospital · 2022 - 2027The ISCHEMIA Trial - SDCC
Clinical TrialStatistician · Awarded by National Institutes of Health · 2011 - 2022The ISCHEMIA Trial - SDCC- Subcontract with NYU
Clinical TrialStatistician · Awarded by New York University · 2017 - 2019View All Grants